BAXBaxter International Inc.

BAX Stock Price, Valuation & Chart | Baxter International Inc.

Compare

$25.280-0.48 (-1.86%)

At close · 16 Oct 2026, 08:00 pm

Sector: Healthcare Industry: Medical - Instruments & Supplies

Overview Financials Dividends Ratios

BAX Historical price chart

BAX Key Stats

Market Capitalization13.07B

PE Ratio12.15

EPS2.08

Trading Volume4.41M

Today's High/Low25.99/25.25

Dividend Yield0.16

52 Week High/Low30.0/15.73

Shares Outstanding517.00M

BAX Financial Statement

BAX Analyst ratings

BAX Analysis & performance metrics

BAX Company profile

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and…

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical…

BAX Management team

Name

Position

David S. Rosenbloom

Executive Vice President & General Counsel

Alok Sonig B.E., Mba

Executive Vice President & Group President of Pharmaceuticals

Anita A. Zielinski

Senior Vice President, Chief Accounting Officer & Controller

Stacey Eisen

SVice President, Chief Communications Officer & Corporate Marketing and President of Baxter Foundation

Joel T. GradeCFO

Executive Vice President & Chief Financial Officer

Andrew P. HiderCEO

Chief Executive Officer, President, Interim Group President of Medical Products & Therapies and Director

Tobi Karchmer M.D., M.S.

Senior Vice President and Chief Medical & Scientific Officer

Charles Rusty PatelCTO

Senior Vice President & Chief Information Officer

Name

Position

David S. Rosenbloom

Executive Vice President & General Counsel

Alok Sonig B.E., Mba

Executive Vice President & Group President of Pharmaceuticals

Anita A. Zielinski

Senior Vice President, Chief Accounting Officer & Controller

Stacey Eisen

SVice President, Chief Communications Officer & Corporate Marketing and President of Baxter Foundation

Joel T. GradeCFO

Executive Vice President & Chief Financial Officer

Andrew P. HiderCEO

Chief Executive Officer, President, Interim Group President of Medical Products & Therapies and Director

Tobi Karchmer M.D., M.S.

Senior Vice President and Chief Medical & Scientific Officer

Charles Rusty PatelCTO

Senior Vice President & Chief Information Officer

Management Team

David S. Rosenbloom

Executive Vice President & General Counsel

Alok Sonig B.E., Mba

Executive Vice President & Group President of Pharmaceuticals

Anita A. Zielinski

Senior Vice President, Chief Accounting Officer & Controller

Stacey Eisen

SVice President, Chief Communications Officer & Corporate Marketing and President of Baxter Foundation

Joel T. GradeCFO

Executive Vice President & Chief Financial Officer

Andrew P. HiderCEO

Chief Executive Officer, President, Interim Group President of Medical Products & Therapies and Director

Tobi Karchmer M.D., M.S.

Senior Vice President and Chief Medical & Scientific Officer

Charles Rusty PatelCTO

Senior Vice President & Chief Information Officer

Management

David S. Rosenbloom

Executive Vice President & General Counsel

Alok Sonig B.E., Mba

Executive Vice President & Group President of Pharmaceuticals

Anita A. Zielinski

Senior Vice President, Chief Accounting Officer & Controller

Stacey Eisen

SVice President, Chief Communications Officer & Corporate Marketing and President of Baxter Foundation

Joel T. GradeCFO

Executive Vice President & Chief Financial Officer

Andrew P. HiderCEO

Chief Executive Officer, President, Interim Group President of Medical Products & Therapies and Director

Tobi Karchmer M.D., M.S.

Senior Vice President and Chief Medical & Scientific Officer

Charles Rusty PatelCTO

Senior Vice President & Chief Information Officer

Total 8 executives

BAX Frequently asked questions

What is Baxter International Inc. (BAX) Stock Price?

Current stock price of Baxter International Inc. (BAX) stock is $25.280. The stock price is -1.86% lower in the session. The intraday range can be seen from this page. Volume of Baxter International Inc. (BAX) stock is 4.41M.

Last updated at 16 Oct 2026, 08:00 pm.

Why is the Baxter International Inc. (BAX) stock price going up or down today?

The stock price of Baxter International Inc. (BAX) can change with earnings, company news, and overall market sentiment. Baxter International Inc. operates in the Healthcare / Medical - Instruments & Supplies market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Baxter International Inc. stock expensive at its current price?

Whether Baxter International Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for BAX on this page is 12.15. EPS on this page is 2.08. Compare those figures with peers and growth expectations before deciding if the current Baxter International Inc. price is justified.

How has the stock price of Baxter International Inc. (BAX) performed historically?

Historical performance for Baxter International Inc. (BAX) is shown on the price chart on this page. Review multi-period moves alongside volume to see how BAX reacted to past earnings and market events.

Should I buy Baxter International Inc. (BAX) stock, at this price?

Buying Baxter International Inc. (BAX) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.